H.C. Wainwright Remains a Hold on PharmaCyte Biotech (PMCB)
March 22 2022 - 11:35AM
TipRanks
In a report released today, Edward White from H.C. Wainwright
maintained a Hold rating on PharmaCyte Biotech (PMCB – Research
Report). The company's shares closed last Tuesday at $2.36, close
to its 52-week low of $1.79. According to TipRanks.com, White is
currently ranked with 0 stars on a 0-5 stars ranking scale, with an
average return of -16.5% and a 26.0% success rate. White covers the
Healthcare sector, focusing on stocks such as Spectrum
Pharmaceuticals, Karyopharm Therapeutics, and TRACON
Pharmaceuticals. PharmaCyte Biotech has an analyst consensus of
Hold.
https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-hold-on-pharmacyte-biotech-pmcb-2?utm_source=advfn.com&utm_medium=referral
PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From May 2022 to Jun 2022
PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From Jun 2021 to Jun 2022